Apic Bio, Inc. — Form D/A

Apic Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2020-11-12. The offering totals $46.1M, of which $42.3M was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-11-12
Form: D/A
Accession: 0001759575-20-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $46.1M
Amount sold: $42.3M
Remaining: $3.8M
Investors: 13
Date of first sale: 2018-11-08
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-326334

Issuer

Name: Apic Bio, Inc.
CIK: 0001759575
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 35 CAMBRIDGEPARK DRIVE, SUITE 350, CAMBRIDGE, MA, 02140-2325
Phone: 857-302-3757

Officers, directors & promoters (6)

Name	Role	Location
Jason Dinges	Director	New Canaan, CT
John Reilly	Director	Dallas, TX
John Reilly	Executive Officer	Dallas, TX
Stephen Hoffman	Director	Vancouver, A1
Christian Mueller	Director	Cambridge, MA
Stephanie O'Brien, J.D.	Director	Cambridge, MA

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2022-07-28	D/A	$8.3M	$8.3M
2022-03-09	D/A	$8.0M	$4.5M
2021-12-30	D	$7.0M	$4.0M
2021-05-12	D	$12.7M	$4.7M
2019-12-30	D/A	$40.0M	$30.2M
2018-11-21	D	$40.0M	$10.0M

More